Table 4 Combined AUC ROC curve data.

From: Inflammatory indices obtained from routine blood tests show an inflammatory state associated with disease progression in engineered stone silicosis patients

 

Biomarkers

AUC

95% CI

P

HC vs. SS

LAF

0.8767

0.7692 to 0.9842

 < 0.0001

LAF-SIRI

0.8889

0.7779 to 0.9999

 < 0.0001

LAF-SIRI-FRT

nd

nd

nd

HC vs. PMF

LAF

0.9444

0.8793 to 1.000

 < 0.0001

LAF-SIRI

1.000

1.000

 < 0.0001

LAF-SIRI-FRT

nd

nd

nd

SS vs. PMF

LAF

0.7263

0.5981 to 0.8546

0.0022

LAF-SIRI

0.7891

0.6765 to 0.9017

 < 0.0001

LAF-SIRI-FRT

0.9143

0.8410 to 0.9876

 < 0.0001

  1. LAF, combined LDH-ACE-fibrinogen; LAF-SIRI, LAF plus SIRI index; LAF-SIRI-FRT, LAF-SIRI plus FVC and DLCO; AUC, area under the ROC curve; 95% CI, 95% confidence interval; P, p value.
Back to article page